A Non-interventional Study of Nab-paclitaxel (Abraxane) in Combination With Carboplatin as First Line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NEPTUN)
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2018
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms NEPTUN
- 05 Jun 2018 Planned End Date changed from 1 Nov 2020 to 1 Mar 2022.
- 05 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Sep 2019.
- 20 Oct 2016 Status changed from not yet recruiting to recruiting.